{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:33:05Z","timestamp":1761561185477},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.nucmedbio.2007.06.010","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T11:26:49Z","timestamp":1188991609000},"page":"887-896","source":"Crossref","is-referenced-by-count":36,"title":["Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF"],"prefix":"10.1016","volume":"34","author":[{"given":"Meiduo","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Scollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Vallis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2007.06.010_bib1","first-page":"161","article-title":"Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma","volume":"48","author":"Ro","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib2","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","article-title":"The epidermal growth factor receptor pathway: a model for targeted therapy","volume":"12","author":"Scaltriti","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM198010093031511","article-title":"Autocrine secretion and malignant transformation of cells","volume":"303","author":"Sporn","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-005-9011-0","article-title":"EGFR signaling pathways in breast cancers: from traditional signal transduction to direct nuclear translocalization","volume":"95","author":"Lo","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.bjc.6602941","article-title":"Nuclear EGFR signaling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival","volume":"94","author":"Lo","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/0008-5472.338.65.1","article-title":"Novel prognostic value of nuclear EGF receptor in breast cancer","volume":"65","author":"Lo","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2005.05.007","article-title":"Nuclear interaction of EGFR and STAT3 in the activation of the iNOS\/NO pathway","volume":"7","author":"Lo","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mc.20147","article-title":"Co-regulation of B-Myb expression by E2F1 and EGF receptor","volume":"45","author":"Hanada","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.cr.7290133","article-title":"The role of nitric oxide in cancer","volume":"12","author":"Xu","year":"2002","journal-title":"Cell Res"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ncb0901-802","article-title":"Nuclear localization of EGF receptor and its potential new role as a transcription factor","volume":"3","author":"Lin","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib11","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00018-003-3037-4","article-title":"Cell cycle regulation by the B-Myb transcription factor","volume":"60","author":"Joaquin","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib12","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/jcb.20876","article-title":"Nuclear\u2013cytoplasmic transport of EGFR involves receptor endocytosis, importin \u03b21 and CRM1","volume":"98","author":"Lo","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib13","first-page":"1479","article-title":"Cancer therapy with Auger electrons: are we almost there?","volume":"44","author":"Kassis","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib14","first-page":"701","article-title":"A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications","volume":"45","author":"Reilly","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib15","first-page":"429","article-title":"111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR","volume":"41","author":"Reilly","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib16","first-page":"1469","article-title":"Antitumour effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts","volume":"44","author":"Chen","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib17","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1083\/jcb.98.6.2148","article-title":"Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: ligand and receptor dynamics","volume":"98","author":"Dunn","year":"1984","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib18","first-page":"1023","article-title":"Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an Auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer","volume":"47","author":"Reilly","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib19","first-page":"903","article-title":"A comparison of EGF and mAb 528 labeled with 111In for imaging human breast cancer","volume":"41","author":"Reilly","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00259-005-1908-7","article-title":"Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer","volume":"33","author":"Hu","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib21","first-page":"497","article-title":"Biomolecules as targeting vehicles for in situ radiotherapy of malignancies","volume":"Vol. 2","author":"Reilly","year":"2005"},{"key":"10.1016\/j.nucmedbio.2007.06.010_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/1084978041979616","article-title":"Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]BZ-DTPA-hEGF in normal mice","volume":"19","author":"Tolmachev","year":"2004","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805107001758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805107001758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T01:32:19Z","timestamp":1684027939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805107001758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0969805107001758"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.06.010","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}